Pharmaceutical agents

Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Particulate form

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514415, 548507, A61K 916, A61K 920, C07D20910

Patent

active

059938595

ABSTRACT:
The invention provides a pharmaceutical composition comprising a particular physical form of N-[4-[5-(cyclopentyloxycarbonyl)amino-1-methylindol-3-yl-methyl]-3-methoxy benzoyl]-2-methyl-benzenesulphonamide and polyvinylpyrrolidone. It also provides methods for preparing this physical form, and another physical form of N-[4-[5-(cyclopentyloxycarbonyl)amino-1-methylindol-3-yl-methyl]-3-methoxy benzoyl]-2-methylbenzenesulphonamide useful in the preparation of the first mentioned physical form. The compositions are useful in the treatment of diseases in which leukotrienes are implicated, for example asthma.

REFERENCES:
patent: 5294636 (1994-03-01), Edwards et al.
patent: 5319097 (1994-06-01), Holohan
T.S. Kondrat'eva, The Technology of Therapeutic Forms, Meditsina, 1991, pp. 85-88, including translation.
I. M. Rabinovich, The Use of Polymers in Medicine, Leingrad Meditsina, 1972, pp. 16-17, including translation.
Haleblian, J., et al., "Pharmaceutical Applications of Polymorphism", J. Pharmaceutical Sciences, vol. 58, No. 8, Aug. 1969, pp. 911-929.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Pharmaceutical agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical agents will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1668472

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.